PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 164 filers reported holding PRECIGEN INC in Q3 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,666 | +23.5% | 6,807 | 0.0% | 0.00% | – |
| Q2 2023 | $7,828 | +8.5% | 6,807 | 0.0% | 0.00% | – |
| Q1 2023 | $7,215 | -24.8% | 6,807 | +7.8% | 0.00% | – |
| Q4 2022 | $9,597 | -26.4% | 6,314 | +2.6% | 0.00% | -100.0% |
| Q3 2022 | $13,042 | -77.2% | 6,152 | -60.0% | 0.00% | 0.0% |
| Q4 2021 | $57,104 | -33.0% | 15,392 | -9.9% | 0.00% | 0.0% |
| Q3 2021 | $85,224 | -48.3% | 17,079 | -32.5% | 0.00% | -50.0% |
| Q2 2021 | $164,936 | +20.2% | 25,297 | +27.0% | 0.00% | 0.0% |
| Q1 2021 | $137,242 | -28.3% | 19,919 | +6.2% | 0.00% | -33.3% |
| Q4 2020 | $191,362 | +182.8% | 18,761 | -3.0% | 0.00% | +200.0% |
| Q3 2020 | $67,673 | -45.9% | 19,335 | -22.9% | 0.00% | -50.0% |
| Q2 2020 | $125,084 | +42.6% | 25,067 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $87,727 | – | 25,802 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |